RWA Wealth Partners’s Edwards Lifesciences EW Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Shares Change % | Capital Flow | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2025
Q2 | $204K | Buy |
+2,605
| New | +$204K | ﹤0.01% | 576 |
|
|
2025
Q1 | – | Sell |
-3,120
| Closed | -$231K | – | 552 |
|
|
2024
Q4 | $231K | Hold |
3,120
| – | – | ﹤0.01% | 523 |
|
|
2024
Q3 | $206K | Sell |
3,120
-2,543
| -45% | -$168K | ﹤0.01% | 541 |
|
|
2024
Q2 | $523K | Buy |
5,663
+110
| +2% | +$10.2K | 0.01% | 386 |
|
|
2024
Q1 | $531K | Buy |
5,553
+2,433
| +78% | +$232K | 0.01% | 390 |
|
|
2023
Q4 | $238K | Buy |
+3,120
| New | +$238K | ﹤0.01% | 482 |
|
|
2023
Q3 | – | Sell |
-2,425
| Closed | -$229K | – | 378 |
|
|
2023
Q2 | $229K | Buy |
+2,425
| New | +$229K | 0.01% | 301 |
|
|
2018
Q3 | – | Sell |
-69
| Closed | -$3K | – | 385 |
|
|
2018
Q2 | $3K | Hold |
69
| – | – | ﹤0.01% | 707 |
|
|
2018
Q1 | $3K | Buy |
+69
| New | +$3K | ﹤0.01% | 522 |
|